News

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...